98%
921
2 minutes
20
Background: The accurate measurement of the incidence of schizophrenia can inform public policy and ensure equitable allocation of limited resources. First contact cases under-estimates the true incidence because of later transitions to schizophrenia. This study aimed to determine the:(i)24 months cumulative incidence of treated DSM-5 schizophrenia diagnosed during treatment at the Early Psychosis Prevention and Intervention Centre (EPPIC) service by including cases of first episode psychosis (FEP) which subsequently transitioned to a diagnosis of schizophrenia; (ii) extent of the under-estimation by using first contact cases; and (iii) proportion and predictors of transition to schizophrenia or bipolar disorder.
Methods: This observational study included all consecutive cases of FEP for people aged 15-24 who attended the EPPIC service from 2011 to 2016, data was recorded prospectively but collected by researchers retrospectively. Poisson regression and Cox regression were used to determine incidence rate ratios and hazard ratios respectively.
Results: At presentation, of the 1220 young people with a FEP, 17.2 % had a diagnosis of schizophrenia compared to 30.2 % after a median of 93 weeks (I.Q.R.: 62-106). The incidence rates of first contact diagnosis of schizophrenia ranged from 17.6 to 28.2 per 100,000 and the cumulative incidence rate ranged from 28.2 to 42.3. The incidence of schizophrenia was 57 % higher with the cumulative method (IRR = 1.57,95%C.I.: 1.30-1.90,p < .001). At discharge, 30.2 % met criteria for schizophrenia and 16.3 % for bipolar disorder.
Conclusions: Even when considering the limitations of the study, such as the narrow age bracket of the participants, the cumulative incidence of schizophrenia should be used to determine a more accurate incidence.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.schres.2025.06.005 | DOI Listing |
Pharmacotherapy
September 2025
Department of Biomedical Informatics, School of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Background: Omeprazole, a widely used proton pump inhibitor, has been associated with rare but serious adverse events such as myopathy. Previous research suggests that concurrent use of omeprazole with fluconazole, a potent cytochrome P450 (CYP) 2C19/3A4 inhibitor, may increase the risk of myopathy. However, the contribution of genetic polymorphisms in CYP enzymes remains unclear.
View Article and Find Full Text PDFZhong Nan Da Xue Xue Bao Yi Xue Ban
May 2025
Department of Outpatient, Third Xiangya Hospital, Central South University, Changsha 410013.
Objectives: Urinary calculi are characterized by a high recurrence rate, and patients' adherence to self-management after discharge directly affects health outcomes. Traditional offline follow-up models often face problems such as poor compliance and uneven allocation of medical resources, making it difficult to meet individualized health management needs. Remote follow-up provides a novel solution to optimize long-term management, improve health literacy, and enhance clinical outcomes.
View Article and Find Full Text PDFZhong Nan Da Xue Xue Bao Yi Xue Ban
May 2025
Department of Urology, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Objectives: Bladder cancer is a common malignancy with high incidence and poor prognosis. N-methyladenosine (mA) modification is widely involved in diverse physiological processes, among which the mA recognition protein YTH N-methyladenosine RNA binding protein F2 (YTHDF2) plays a crucial role in bladder cancer progression. This study aims to elucidate the molecular mechanism by which O-linked -acetylglucosamine (O-GlcNAc) modification of YTHDF2 regulates its downstream target, period circadian regulator 1 (), thereby promoting bladder cancer cell proliferation.
View Article and Find Full Text PDFZhong Nan Da Xue Xue Bao Yi Xue Ban
May 2025
Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha 410008.
Objectives: Patients with connective tissue diseases (CTD) have a high incidence of cardiac involvement, which often presents insidiously and can progress rapidly, making it one of the leading causes of death. Multiparametric cardiovascular magnetic resonance (CMR) provides a comprehensive quantitative evaluation of myocardial injury and is emerging as a valuable tool for detecting cardiac involvement in CTD. This study aims to investigate the correlations between CMR features and serological biomarkers in CTD patients, assess their potential clinical value, and further explore the impact of pre-CMR immunotherapy intensity on CMR-specific parameters, thereby evaluating the role of CMR in the early diagnosis of CTD-related cardiac involvement.
View Article and Find Full Text PDFParkinson's disease (PD) is the fastest-growing neurodegenerative disease in the world and appears to be an emerging epidemic in Africa, where counteractive measures have become necessary. Previous reports have highlighted the limited epidemiological and clinical PD research in Africa but overlooked the poor preclinical PD research output of the continent. Because preclinical research is a bedrock for translating basic scientific research into clinical practice, a weak preclinical research foundation can hamper advancement in epidemiological and clinical investigations.
View Article and Find Full Text PDF